278 related articles for article (PubMed ID: 24030132)
21. New statin labeling requirements: an overview.
Hicks MR; Murphy BL
Consult Pharm; 2013 Nov; 28(11):742-4. PubMed ID: 24217194
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of pharmacist interventions in a head and neck medical oncology clinic.
Lau KM; Saunders IM; Sacco AG; Barnachea LC
J Oncol Pharm Pract; 2020 Sep; 26(6):1390-1396. PubMed ID: 31937188
[TBL] [Abstract][Full Text] [Related]
23. Columbus Air Force Base medication profile intervention practice innovation.
Guill JV; Griffin LA; Goodwin TD
J Am Pharm Assoc (2003); 2008; 48(5):654-8. PubMed ID: 18826905
[TBL] [Abstract][Full Text] [Related]
24. Avoiding patient morbidity: Updated statin drug interactions and risks for patient harm.
Finks SW; Campbell JD
Nurse Pract; 2014 Nov; 39(11):45-51. PubMed ID: 25325525
[TBL] [Abstract][Full Text] [Related]
25. Implementation of the Pharmacy Practice Model Initiative within comprehensive cancer centers.
Smith MB; Gumpper KF; Riebandt G; Handel EM
Am J Health Syst Pharm; 2014 Oct; 71(19):1647-60. PubMed ID: 25225450
[TBL] [Abstract][Full Text] [Related]
26. Best practices in specialty pharmacy management.
Patterson CJ
J Manag Care Pharm; 2013; 19(1):42-8. PubMed ID: 23383699
[TBL] [Abstract][Full Text] [Related]
27. Analysis of community chain pharmacists' interventions on electronic prescriptions.
Warholak TL; Rupp MT
J Am Pharm Assoc (2003); 2009; 49(1):59-64. PubMed ID: 19196598
[TBL] [Abstract][Full Text] [Related]
28. Role of student pharmacists in the identification and prevention of medication-related problems.
Abdelhalim D; Mohundro BL; Evans JD
J Am Pharm Assoc (2003); 2011; 51(5):627-30. PubMed ID: 21896462
[TBL] [Abstract][Full Text] [Related]
29. Persistent use of against-label statin-fibrate combinations from 2003-2009 despite United States Food and Drug Administration dose restrictions.
Alford JC; Saseen JJ; Allen RR; Nair KV
Pharmacotherapy; 2012 Jul; 32(7):623-30. PubMed ID: 22570173
[TBL] [Abstract][Full Text] [Related]
30. The future of health-system pharmacy: opportunities and challenges in practice model change.
Zellmer WA
Ann Pharmacother; 2012 Apr; 46(4):S41-5. PubMed ID: 22499740
[TBL] [Abstract][Full Text] [Related]
31. Clinical pharmacist intervention and the proportion of diabetes patients attaining prevention objectives in a multispecialty medical group.
Padiyara RS; D'Souza JJ; Rihani RS
J Manag Care Pharm; 2011; 17(6):456-62. PubMed ID: 21787031
[TBL] [Abstract][Full Text] [Related]
32. The impact of pharmacy computerised clinical decision support on prescribing, clinical and patient outcomes: a systematic review of the literature.
Robertson J; Walkom E; Pearson SA; Hains I; Williamsone M; Newby D
Int J Pharm Pract; 2010 Apr; 18(2):69-87. PubMed ID: 20441116
[TBL] [Abstract][Full Text] [Related]
33. Initial experience with antiarrhythmic medication monitoring by clinical pharmacists in an outpatient setting: a retrospective review.
Snider M; Kalbfleisch S; Carnes CA
Clin Ther; 2009 Jun; 31(6):1209-18. PubMed ID: 19695388
[TBL] [Abstract][Full Text] [Related]
34. Non-dispensing pharmacist integrated in the primary care team: effect on the quality of physician's prescribing, a non-randomised comparative study.
Sloeserwij VM; Zwart DLM; Hazen ACM; Poldervaart JM; Leendertse AJ; de Bont AA; Bouvy ML; de Wit NJ; de Gier HJ
Int J Clin Pharm; 2020 Oct; 42(5):1293-1303. PubMed ID: 32789761
[TBL] [Abstract][Full Text] [Related]
35. Expanding pharmacy practice through the use of pharmacy technicians as process navigators to facilitate patient access of oral anticancer agents.
Lau G; Alwan L; Chi M; Lentz M; Hone K; Segal E
J Am Pharm Assoc (2003); 2019; 59(4):586-592. PubMed ID: 31036528
[TBL] [Abstract][Full Text] [Related]
36. Effect of a Pharmacist-Driven Monitoring Program and Electronic Health Record on Bleeding Log Completeness and Documentation.
Shay B; Kennerly-Shah J; Neidecker M; Beatty S; Witkoff L; Brown N; Kraut E
J Manag Care Spec Pharm; 2018 Oct; 24(10):1034-1039. PubMed ID: 30247104
[TBL] [Abstract][Full Text] [Related]
37. Integration of collaborative medication therapy management in a safety net patient-centered medical home.
Moczygemba LR; Goode JV; Gatewood SB; Osborn RD; Alexander AJ; Kennedy AK; Stevens LP; Matzke GR
J Am Pharm Assoc (2003); 2011; 51(2):167-72. PubMed ID: 21382806
[TBL] [Abstract][Full Text] [Related]
38. Residency requirement for pharmacists providing direct patient care.
Nahata MC
Ann Pharmacother; 2010 Nov; 44(11):1822-5. PubMed ID: 20923948
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the impact of a tele-ICU pharmacist on the management of sedation in critically ill mechanically ventilated patients.
Forni A; Skehan N; Hartman CA; Yogaratnam D; Njoroge M; Schifferdecker C; Lilly CM
Ann Pharmacother; 2010 Mar; 44(3):432-8. PubMed ID: 20164471
[TBL] [Abstract][Full Text] [Related]
40. Prescriber acceptance rate of pharmacists' recommendations.
Doellner JF; Dettloff RW; DeVuyst-Miller S; Wenstrom KL
J Am Pharm Assoc (2003); 2017; 57(3S):S197-S202. PubMed ID: 28408169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
